The Joint Corp (JYNT)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at The Joint Corp.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 3 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Basics
Performance
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
This stock currently pays no dividend.
Quality & Screener
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Analysts & Price Target
The price target sits 20.5% above the current price.
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Next Reporting Date
- Expected Earnings per Share
- 0.11 $
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | -0.19 | – | -38 | -225.10 | – | 4 | 4 |
| 2025: Q1 | 0.07 | 2.20 | 13 | 7.30 | 7.40 | -4 | -4 |
| 2025: Q2 | 0.01 | – | 13 | 5.20 | 0.70 | 1 | 0 |
| 2025: Q3 | 0.06 | – | 13 | -55.70 | 6.40 | 2 | 2 |
| 2025: Q4 | 0.07 | – | 15 | – | 6.50 | 3 | 3 |
| 2026: Q1 | 0.09 | 34.20 | 15 | 13.30 | 8.80 | -2 | -2 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
About the Company
The Joint Corp. betreibt und franchisiert chiropraktische Kliniken in den USA.
| Employees | 202 |
|---|---|
| Headquarters | Scottsdale, AZ |
| Website | thejoint.com |
| IPO Date | 11. Nov 2014 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Sanjiv Razdan | CEO, President & Director | 1970 |
| Scott Justin Bowman | Chief Financial Officer | 1967 |
| Ron Stilwell | Senior Vice President of Operations & Patient Experience | – |
| Charles Nelles | Chief Technology Officer | – |
| Steven Knauf | Vice President of Chiropractic & Compliance | – |
| Andra J. Terrell | SVP, Corporate Secretary & General Counsel, | – |
| Debbie L. Gonzalez | Chief Marketing Officer | – |
| Beth Gross | Chief Human Resources Officer | – |
| Craig M. Sherwood | SVP & Chief Development Officer | 1967 |
| Craig P. Colmar J.D. | Secretary | 1953 |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 21. Apr 2026 | Charles E Jobson | Major Shareholder | Buy | 509 | 8.58 | 4,367 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.